Lilly’s Mounjaro Gains FDA Approval for Heart Risk Reduction
INDIANAPOLIS, U.S., Aug 28, 2026 Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has...
Ocular Hypertension
Advertisement
Nicox Sets April 2027 FDA Decision Date for NCX 470
SOPHIA ANTIPOLIS, FRANCE, Aug 27, 2026 Nicox SA announced that the U.S. Food and Drug Administration (FDA) has accepted...
Artelo Biosciences Secures U.S. Patent Allowance for ART27.13
Solana Beach, California — August 17, 2026 Artelo Biosciences, Inc. announced that the U.S. Patent and Trademark Office (USPTO)...
Artelo Biosciences Starts Phase 2 Glaucoma Trial
SOLANA BEACH, Calif., August 10, 2026 Artelo Biosciences, Inc. announced that the first patient has been dosed in the...
Advertisement
